View Older Stories View More Recent Stories
-
Roth Keeps Positive View on Rexahn (RNN) Following Equity Raise; Affirms at 'Buy'
-
Roth Capital Trims Ests on Ballard Power (BLDP) Following Q4 Report; Notes Strong Pipeline, Order Book
-
Pershing Gold Completes Private Placement
-
Roth Capital Downgrades Peregrine Pharmaceuticals (PPHM) to Neutral
-
xG Technology, Inc. Announces Pricing of Public Offering
-
OptimizeRx to Present at the 28th Annual ROTH Conference on March 16, 2016
-
Notable Analyst Rating Changes 2/25: (MSCC) (XRAY) (MLNX) Upgraded; (LC) (CNL) (EXAS) Downgraded
-
Cachet Financial Solutions to Present at the 28th Annual ROTH Conference on March 14th, 2016
-
Roth Capital Downgrades PowerSecure (POWR) to Neutral
-
RedHill Biopharma Reports 2015 Fourth Quarter and Full-Year Financial Results
-
Roth Capital Assumed Active Power (ACPW) at Neutral
-
Roth Capital Downgrades Exact Sciences (EXAS) to Neutral
-
InvenSense Inc. Announces Financial Conference Participation for the Fiscal Fourth Quarter 2016
-
Great Basin Scientific (GBSN) Closes $6.3M Equity Raise
-
Great Basin Scientific Closes $6.3 Million Public Offering of Units
-
Roth Sees Continued Momentum for First Solar (FSLR) as 2016 Progresses; Affirms at 'Buy'
-
Newtek to Present at the Raymond James and Roth Capital Partners Investor Conferences in March 2016
-
Roth Capital Downgrades Enphase Energy (ENPH) to Neutral
-
Ultimate Announces Schedule of Investor Conferences for March 2016
-
Pretivm Prices Offering of Common Shares
-
Titan Medical Inc. Announces Closing of Over-Allotment Option
-
Roth Capital Downgrades Calgon Carbon Corp. (CCC) to Neutral
-
Great Basin Scientific (GBSN) Prices 39.2M Common Stock and Warrant Offering at $0.16/Unit
-
Great Basin Scientific Prices $6.3 Million Public Offering of Units
-
No Major Surprises Seen in Gentherm's (THRM) Latest Quarterly Release; Roth Affirms at 'Buy'
-
Adaptive Medias, Inc. Announces Engagement of Investment Banking Firm ROTH Capital Partners to Provide Strategic Advisory Services
-
Mast Therapeutics Closes $8 Million Public Offering
-
Roth Capital Bumps Ests on Canadian Solar (CSIQ) Higher Following Prelim. Q4 Numbers
-
Palatin Tech (PTN) Management Entering Crunch Time on BMT; Roth Affirms at 'Buy'
-
Everspin to Present at ROTH Capital Partners Conference
-
Quantum Materials to Present at ROTH Investment Conference
-
Yuma Energy (YUMA) to Merge with Davis Petroleum Acquisition Corp
-
Yuma Energy, Inc. and Davis Petroleum Acquisition Corp. Announce Merger Agreement
-
Roth Capital Downgrades LivePerson (LPSN) to Neutral
-
Roth Affirms Regeneron (REGN) at 'Buy' Following Q4 Results; Sees Opportunity in Shares on Pullback
-
Mast Therapeutics (MSTX) Prices 29M Offering of Common Stock and Warrants at $0.275/Unit
-
Mast Therapeutics Announces Pricing Of Underwritten Public Offering
-
Roth Capital Partners' Joe Reagor Interviewed by The Gold Report
-
Roth Capital Starts Denison Mines (DNN) at Buy
-
Roth Capital Downgrades SolarCity (SCTY) to Neutral; Sidelined Until Better Execution Appears
-
Mast Therapeutics (MSTX) to Offer Common Stock And Warrants
-
Mast Therapeutics Announces Proposed Public Offering Of Common Stock And Warrants
-
Roth Capital Downgrades Outerwall Inc. (OUTR) to Sell
-
Roth Capital Restarts Capstone Turbine (CPST) at Neutral; PT Moves to $1.60
-
Roth Capital Starts Heritage-Crystal Clean (HCCI) at Buy
-
Results from Cytori's (CYTX) Cell Therapy in ED with RP are 'Promising' - Roth Capital
-
Notable Analyst Rating Changes 2/3: (NPTN) (MNK) (SYNT) Upgraded; (MCHP) (XEL) (MS) Downgraded
-
Roth Capital Restarts Hydrogenics (HYGS) at 'Buy'; Sees Profitability by End of 2016
-
Roth Capital Restarts Plug Power (PLUG) at Neutral; New Air-Cooled Stack to Remain Key in 2016
-
Roth Capital Tranfers Coverage on Ballard Power (BLDP); Reaffirms at 'Buy,' PT of $2

